Drug Profile
Respiratory syncytial virus vaccine - Pierre Fabre
Alternative Names: BBG2Na; F50077; J002X; L0077Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Pierre Fabre
- Class Respiratory syncytial virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Respiratory syncytial virus infections